PharmaShots | Incisive News in 3 Shots

Subscribe Now

Addex

Addex Discontinue P-IIb/III Study of Dipraglurant for the Treatment of Dyskinesia Associated With Parkinson’s Disease

Addex Discontinue P-IIb/III Study of Dipraglurant for the Treatment of Dyskinesia Associated With Parkinson’s Disease

June 17, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us